Navigation Links
Even 6 months or more of hormone therapy treatment does not impact longevity of prostate cancer patients

Prostate cancer patients who receive treatment by way of radiation or surgery with hormone therapy that goes above a 6 month period, does not impact longevity when compared// to patients who have received the treatment for a shorter duration, a recent study has revealed.

"Many patients with high risk prostate cancer are treated with two or more years of hormone therapy based on studies performed over a decade ago," said Cliff Robinson, M.D., lead author of the study and a radiation oncologist at Cleveland Clinic in Cleveland, Ohio. "Our study's findings suggest that treating current patients with shorter-term hormone therapy may not only be equally effective, but also improve their quality of life, due to a lesser degree of treatment side effects."

The authors also found that patients receiving longer than six months of hormone therapy were twice as likely to die as patients who use the treatment for a shorter amount of time. "The reasons why patients receiving longer term hormone therapy may do worse are unclear," said Dr. Robinson, who also cautions, "A number of factors could complicate the issue, and this area needs further investigation before any conclusions can be drawn."

Androgen deprivation therapy is a hormone therapy used to treat prostate cancer by lowering the level of male hormones (androgens) to shrink or slow down the growth of prostate cancer. It has been shown to dramatically slow advanced prostate cancer that has already spread to the lymph nodes or the bone, and improves survival when combined with radiation therapy in advanced prostate cancer that has not already spread.

Several side effects are common to androgen deprivation therapy and are a direct result of decreased androgen levels. Side effects vary significantly depending on the amount and length of time the hormone therapy is given. Potential side effects include reduced sexual desire, impotence, hot flashes, weakening of the bones, breast tenderness or breast growth, as well as other conditions.

The study reviewed 579 patients who were treated at the Cleveland Clinic with high risk prostate cancer from 1996 to 2003. These patients were divided into three groups - one that received no androgen deprivation therapy, one that had received six months or less of androgen deprivation therapy, and one that received more than six months of treatment - to determine if longer use of hormone therapy stopped cancer from growing and lengthened survival.

Source-Eurekalert
'"/>




Related medicine news :

1. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
2. Winter months encourage binge eating
3. Vitamin D Supplement in Teenage Girls essential in Winter months
4. Vitamin D Supplement in Teenage Girls essential in Winter months
5. NHS De-addiction, Rehabilitation waiting time ticking into months
6. HIV/AIDS prevention program extended by 18 months in Bangladesh
7. Thyroid hormone treatment hastens recovery after cardiac surgery
8. Breast feeding can alter hormones
9. Breast cancer risk doubles by high sex hormone levels
10. A hormone may decrease Menopause Symptoms
11. Alcohol injures stress hormone response
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... ... January 20, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh has ... the world. Yisrayl says this generation is a time like no other and society needs ... Bible. , Yisrayl says he does not want to sound like an old bible beater ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, an Australian-based company ... attended the January ECRM Trade Show in Hilton Head, SC, benefiting from outstanding ... range of supplements that keep the body functioning at its peak performance by ...
(Date:1/20/2017)... ... ... Magdalene: Grace is Greater than Sin”: a unique and memorable piece of literature ... Grace is Greater than Sin” is the creation of published author, Brenda Roberts, a ... had little knowledge of the female characters portrayed in the Holy Bible. , ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Christmas in Suffolk”: a story ... Sara Seymour, who lives in Lafayette, Indiana where she works in a daycare and ... and writes. , Published by Christian Faith Publishing, Sara Seymour’s new book is an ...
(Date:1/19/2017)... ... ... the Centers for Medicare & Medicaid Services (CMS) announced over 359,000 clinicians are ... who participate in APMs are paid for the quality of care they give to ... a system that delivers better care and one in which clinicians work together to ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 Conference Call and Webcast to ... ) today announced it will release results for the fourth quarter ... ... host a conference call at 4:30 PM ET on Wednesday, February ... full year 2016 financial results and other corporate activities. To participate ...
(Date:1/19/2017)... , Jan. 19, 2017  Stealth BioTherapeutics Inc. ( ... treat mitochondrial dysfunction, today announced new additions to its ... as Chief Medical Officer, and Daniel Geffken ... that Jim Carr , Pharm.D. has been promoted ... are pleased to welcome Doug and Daniel to our ...
(Date:1/19/2017)... 19, 2017  Abaxis, Inc. (NasdaqGS: ABAX ... instruments and consumables for the medical and veterinary markets ... financial results for the third quarter fiscal year 2017, ... 4:15 p.m. ET on Thursday, January 26, 2017.  The ... fiscal year 2017 after the market closes on Thursday, ...
Breaking Medicine Technology: